-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
المؤلفون: Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California., Wortman JR; Seres Therapeutics, Cambridge, Massachusetts., Burton EM; Strategic Translational Research Initiative Development, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alayli FA; Parker Institute for Cancer Immunotherapy, San Francisco, California., Loo CP; Parker Institute for Cancer Immunotherapy, San Francisco, California., Gautam S; Parker Institute for Cancer Immunotherapy, San Francisco, California., Damania A; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., Densmore J; Parker Institute for Cancer Immunotherapy, San Francisco, California., Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Portage Biotech, Westport, Connecticut., Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California., Wong MC; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Weiner B; Seres Therapeutics, Cambridge, Massachusetts., Hicks N; Seres Therapeutics, Cambridge, Massachusetts., Aunins J; Seres Therapeutics, Cambridge, Massachusetts., McChalicher C; Seres Therapeutics, Cambridge, Massachusetts., Walsh E; Seres Therapeutics, Cambridge, Massachusetts., Tetzlaff MT; Department of Pathology, University of California San Francisco, San Francisco, California., Hamid O; Cutaneous Oncology, The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Boland GM; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Sullivan RJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Grossmann KF; Providence Cancer Institute Franz Clinic, Portland, Oregon., Ajami NJ; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Coherus BioSciences, Redwood City, California., Henn MR; Seres Therapeutics, Cambridge, Massachusetts., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
المصدر: Cancer discovery [Cancer Discov] 2024 Jul 01; Vol. 14 (7), pp. 1161-1175.
نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Multicenter Study
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
مواضيع طبية MeSH: Melanoma*/drug therapy , Gastrointestinal Microbiome*/drug effects , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/pharmacology, Humans ; Female ; Male ; Middle Aged ; Aged ; Immune Checkpoint Inhibitors/therapeutic use ; Nivolumab/therapeutic use ; Nivolumab/administration & dosage ; Biomarkers, Tumor ; Vancomycin/therapeutic use ; Adult ; COVID-19/immunology ; Skin Neoplasms/drug therapy ; Skin Neoplasms/immunology
-
5دورية أكاديمية
المؤلفون: Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Surgery, University of Washington, Seattle., Pollack SM; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
المصدر: JAMA oncology [JAMA Oncol] 2024 Jun 01; Vol. 10 (6), pp. 830-831.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Sarcoma*/therapy , Sarcoma*/pathology, Humans ; Soft Tissue Neoplasms/therapy ; Soft Tissue Neoplasms/pathology ; Soft Tissue Neoplasms/secondary ; Radioimmunotherapy/methods ; Neoplasm Metastasis
-
6دورية أكاديمية
المؤلفون: Pothuri VS; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Hogg GD; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Conant L; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Borcherding N; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., James CA; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Mudd J; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Williams G; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Seo YD; Department of Surgery, University of Washington School of Medicine, Seattle, WA, USA.; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Hawkins WG; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO USA., Pillarisetty VG; Department of Surgery, University of Washington School of Medicine, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA USA., DeNardo DG; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO USA., Fields RC; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO USA.
المصدر: Oncoimmunology [Oncoimmunology] 2024 Mar 15; Vol. 13 (1), pp. 2320411. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
-
7دورية أكاديمية
المؤلفون: Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Surgery, University of Washington, Seattle., Lu H; Seagen Inc, Bothell, Washington., Black G; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Smythe K; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Yu Y; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hsu C; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Ng J; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle.; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Hermida de Viveiros P; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Warren EH; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Schroeder BA; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., O'Malley RB; Department of Radiology, University of Washington, Seattle., Cranmer LD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Loggers ET; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Wagner MJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Bonham L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Pillarisetty VG; Department of Surgery, University of Washington, Seattle., Kane G; Department of Radiation Oncology, University of Washington, Seattle., Berglund P; HDT Bio, Seattle, Washington., Hsu FJ; Apexigen, San Carlos, California., Mi X; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Alexiev BA; Department of Pathology, Northwestern University, Chicago, Illinois., Pierce RH; Sensei Biotherapeutics Inc, Boston, Massachusetts., Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Jones RL; Royal Marsden and Institute for Cancer Research, London, UK., Ter Meulen J; Obsidian Therapeutics, Cambridge, Massachusetts., Kim EY; Department of Radiation Oncology, University of Washington, Seattle., Pollack SM; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
المصدر: JAMA oncology [JAMA Oncol] 2023 Dec 01; Vol. 9 (12), pp. 1660-1668.
نوع المنشور: Controlled Clinical Trial; Clinical Trial, Phase I; Journal Article
بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Soft Tissue Neoplasms*/drug therapy , Soft Tissue Neoplasms*/radiotherapy , Sarcoma*/drug therapy , Sarcoma*/radiotherapy, Humans ; Female ; Aged ; Male ; Toll-Like Receptor 4/agonists ; T-Lymphocytes ; Receptors, Antigen, T-Cell
-
8دورية أكاديمية
المؤلفون: Zhang X; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Institute for Translational Epidemiology & Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Irajizad E; Division of Basic Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hoffman KL; Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Fahrmann JF; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Cancer Prevention and Population Sciences, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li F; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Seo YD; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Browman GJ; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dennison JB; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vykoukal J; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Luna PN; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Siu W; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu R; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Murage E; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ajami NJ; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McQuade JL; Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Long JP; Division of Basic Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Do KA; Division of Basic Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lampe JW; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Basen-Engquist KM; Division of Cancer Prevention and Population Sciences, Department of Heath Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Okhuysen PC; Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kopetz S; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hanash SM; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Cancer Prevention and Population Sciences, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Petrosino JF; Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Scheet P; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daniel CR; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: cdaniel@mdanderson.org.
المصدر: EBioMedicine [EBioMedicine] 2023 Dec; Vol. 98, pp. 104873. Date of Electronic Publication: 2023 Nov 30.
نوع المنشور: Randomized Controlled Trial; Journal Article
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
مواضيع طبية MeSH: Prebiotics* , Gastrointestinal Microbiome*, Humans ; Proteomics ; Obesity/microbiology ; Inflammation
-
9دورية أكاديمية
المؤلفون: Cass SH; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Tobin JWD; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Seo YD; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Gener-Ricos G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston., Keung EZ; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Burton EM; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Davies MA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., McQuade JL; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Lazar AJ; Departments of Pathology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, USA., Mason R; Gold Coast University Hospital, Southport., Millward M; University of Western Australia, Perth., Sandhu S; Peter Macallum Cancer Centre, Melbourne., Khoo C; Peter Macallum Cancer Centre, Melbourne., Warburton L; Fiona Stanley Hospital, Perth; Edith Cowan University, Joondalup; Future Health Research and Innovation Fund/Raine Clinician Research Fellowship., Guerra V; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston., Haydon A; Alfred Hospital, Melbourne., Dearden H; Melanoma Institute Australia, The University of Sydney, Sydney., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney; Westmead Hospital, Sydney, Australia., Smith JL; Westmead Hospital, Sydney, Australia., Mollee P; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Burgess M; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Mapp S; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Keane C; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Atkinson V; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Parikh SA; Mayo Clinic, Rochester, USA., Markovic SN; Mayo Clinic, Rochester, USA., Ding W; Mayo Clinic, Rochester, USA., Call TG; Mayo Clinic, Rochester, USA., Hampel PJ; Mayo Clinic, Rochester, USA., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney., Wargo JA; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jwargo@mdanderson.org., Ferrajoli A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston.
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Sep; Vol. 34 (9), pp. 796-805. Date of Electronic Publication: 2023 Jul 04.
نوع المنشور: Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/complications , Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Melanoma*/pathology, Adult ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Australia ; Progression-Free Survival ; Retrospective Studies
-
10دورية أكاديمية
المؤلفون: Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ajami N; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
المصدر: Nature medicine [Nat Med] 2023 Aug; Vol. 29 (8), pp. 1910-1911.
نوع المنشور: Journal Article; Comment
بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
مواضيع طبية MeSH: Gastrointestinal Tract* , Neoplasms*/therapy, Humans